A class action lawsuit has been filed in Canada against Japanese drug-maker Takeda Pharmaceuticals. The litigation claims that the company’s Type 2 diabetes drug Actos caused serious side effects, including at least one death from bladder cancer.
According to court documents, the class action lawsuit was filed in an Ontario Superior Court of Justice. In addition to naming Takeda Pharmaceuticals, the action also names Eli Lilly, who once marketed and distributed the drug. The plaintiffs claim that both companies intentionally failed to properly warn patients and physicians of the potential health risks, including an increased risk for bladder cancer among individuals who used Actos for a year or more.
The lead plaintiff in the class action is a Toronto woman who was first prescribed Actos in 2002. The woman’s family filed suit against Takeda and Eli Lilly after she died in April after an extended battle with bladder cancer. The woman’s daughter, a registered nurse, has publicly stated that if she or her mother had known of the risks, then she would never have taken Actos to treat her Type 2 diabetes.
Actos first went on sale in Canada in 2000. Currently, neither Canadian nor American health officials have revealed any plans to recall the drug. In June 2011, Actos was recalled in both France and Germany after the results of a study were published which indicated that there was a potential link between pioglitazone, the active ingredient in Actos, and increased rates of bladder cancer. Despite this limited recall, the European Medical Agency issued a statement in November reaffirming its support of Actos for use among adult diabetes patients for whom other treatment methods were ineffective.
Following the publication of this study, the U.S. Food and Drug Administration issued an updated safety warning, advising both doctors and diabetes patients of potential Actos side effects. The FDA is currently conducting an ongoing safety review of the drug to determine whether the risks may outweigh the benefits.
Numerous lawsuits have already been filed in the U.S. against Takeda Pharmaceuticals from patients and families who also claim that the drug-maker knew of the bladder cancer risk but continued to aggressively market Actos. The drug is currently one of Takeda’s biggest moneymakers, generating nearly $5 billion in revenue in 2010 alone.
As the number of lawsuits continues to mount each day, consumer advocacy groups are urging current Actos users to contact an experienced personal injury attorney to discuss their case. If you or a loved one has developed bladder cancer after taking Actos, you must take action immediately to protect your rights.
The law firm of Nadrich & Cohen LLP is currently investigating claims from Actos users in all 50 states. Concerned patients may schedule a free initial case evaluation by calling 1-800-722-0765 or by visiting the firm’s online Actos resource center. All cases are accepted on a contingency basis, meaning there is never a fee unless a money judgment is recovered on your behalf. Contact Nadrich & Cohen today to put their expert Actos injury attorneys to work for you.